000138197 001__ 138197
000138197 005__ 20240826163725.0
000138197 0247_ $$2doi$$a10.3389/fneur.2015.00216
000138197 0247_ $$2pmid$$apmid:26528237
000138197 0247_ $$2pmc$$apmc:PMC4606063
000138197 0247_ $$2altmetric$$aaltmetric:4627902
000138197 037__ $$aDZNE-2020-04519
000138197 041__ $$aEnglish
000138197 082__ $$a610
000138197 1001_ $$0P:(DE-HGF)0$$aReijs, Babette L R$$b0$$eCorresponding author
000138197 245__ $$aThe Central Biobank and Virtual Biobank of BIOMARKAPD: A Resource for Studies on Neurodegenerative Diseases.
000138197 260__ $$aLausanne$$bFrontiers Research Foundation$$c2015
000138197 264_1 $$2Crossref$$3online$$bFrontiers Media SA$$c2015-10-15
000138197 3367_ $$2DRIVER$$aarticle
000138197 3367_ $$2DataCite$$aOutput Types/Journal article
000138197 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1724675014_21470
000138197 3367_ $$2BibTeX$$aARTICLE
000138197 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000138197 3367_ $$00$$2EndNote$$aJournal Article
000138197 520__ $$aBiobanks are important resources for biomarker discovery and assay development. Biomarkers for Alzheimer's and Parkinson's disease (BIOMARKAPD) is a European multicenter study, funded by the EU Joint Programme-Neurodegenerative Disease Research, which aims to improve the clinical use of body fluid markers for the diagnosis and prognosis of Alzheimer's disease (AD) and Parkinson's disease (PD). The objective was to standardize the assessment of existing assays and to validate novel fluid biomarkers for AD and PD. To support the validation of novel biomarkers and assays, a central and a virtual biobank for body fluids and associated data from subjects with neurodegenerative diseases have been established. In the central biobank, cerebrospinal fluid (CSF) and blood samples were collected according to the BIOMARKAPD standardized pre-analytical procedures and stored at Integrated BioBank of Luxembourg. The virtual biobank provides an overview of available CSF, plasma, serum, and DNA samples at each site. Currently, at the central biobank of BIOMARKAPD samples are available from over 400 subjects with normal cognition, mild cognitive impairment (MCI), AD, frontotemporal dementia (FTD), vascular dementia, multiple system atrophy, progressive supranuclear palsy, PD, PD with dementia, and dementia with Lewy bodies. The virtual biobank contains information on over 8,600 subjects with varying diagnoses from 21 local biobanks. A website has been launched to enable sample requests from the central biobank and virtual biobank.
000138197 536__ $$0G:(DE-HGF)POF3-344$$a344 - Clinical and Health Care Research (POF3-344)$$cPOF3-344$$fPOF III$$x0
000138197 588__ $$aDataset connected to CrossRef, PubMed,
000138197 7001_ $$aTeunissen, Charlotte E$$b1
000138197 7001_ $$aGoncharenko, Nikolai$$b2
000138197 7001_ $$aBetsou, Fay$$b3
000138197 7001_ $$aBlennow, Kaj$$b4
000138197 7001_ $$aBaldeiras, Inês$$b5
000138197 7001_ $$0P:(DE-2719)2810593$$aBrosseron, Frederic$$b6$$udzne
000138197 7001_ $$aCavedo, Enrica$$b7
000138197 7001_ $$aFladby, Tormod$$b8
000138197 7001_ $$aFroelich, Lutz$$b9
000138197 7001_ $$aGabryelewicz, Tomasz$$b10
000138197 7001_ $$aGurvit, Hakan$$b11
000138197 7001_ $$aKapaki, Elisabeth$$b12
000138197 7001_ $$aKoson, Peter$$b13
000138197 7001_ $$aKulic, Luka$$b14
000138197 7001_ $$aLehmann, Sylvain$$b15
000138197 7001_ $$aLewczuk, Piotr$$b16
000138197 7001_ $$aLleó, Alberto$$b17
000138197 7001_ $$0P:(DE-2719)2810915$$aMaetzler, Walter$$b18$$udzne
000138197 7001_ $$ade Mendonça, Alexandre$$b19
000138197 7001_ $$aMiller, Anne-Marie$$b20
000138197 7001_ $$aMolinuevo, José L$$b21
000138197 7001_ $$aMollenhauer, Brit$$b22
000138197 7001_ $$aParnetti, Lucilla$$b23
000138197 7001_ $$aRot, Uros$$b24
000138197 7001_ $$0P:(DE-2719)2812035$$aSchneider, Anja$$b25$$udzne
000138197 7001_ $$aSimonsen, Anja Hviid$$b26
000138197 7001_ $$aTagliavini, Fabrizio$$b27
000138197 7001_ $$aTsolaki, Magda$$b28
000138197 7001_ $$aVerbeek, Marcel M$$b29
000138197 7001_ $$aVerhey, Frans R J$$b30
000138197 7001_ $$aZboch, Marzena$$b31
000138197 7001_ $$aWinblad, Bengt$$b32
000138197 7001_ $$aScheltens, Philip$$b33
000138197 7001_ $$aZetterberg, Henrik$$b34
000138197 7001_ $$aVisser, Pieter Jelle$$b35
000138197 77318 $$2Crossref$$3journal-article$$a10.3389/fneur.2015.00216$$b : Frontiers Media SA, 2015-10-15$$tFrontiers in Neurology$$v6$$x1664-2295$$y2015
000138197 773__ $$0PERI:(DE-600)2564214-5$$a10.3389/fneur.2015.00216$$gVol. 6$$p216$$q6$$tFrontiers in neurology$$v6$$x1664-2295$$y2015
000138197 8567_ $$2Pubmed Central$$uhttp://www.ncbi.nlm.nih.gov/pmc/articles/PMC4606063
000138197 8564_ $$uhttps://pub.dzne.de/record/138197/files/fneur-06-00216.pdf$$yOpenAccess
000138197 8564_ $$uhttps://pub.dzne.de/record/138197/files/fneur-06-00216.gif?subformat=icon$$xicon$$yOpenAccess
000138197 8564_ $$uhttps://pub.dzne.de/record/138197/files/fneur-06-00216.jpg?subformat=icon-1440$$xicon-1440$$yOpenAccess
000138197 8564_ $$uhttps://pub.dzne.de/record/138197/files/fneur-06-00216.jpg?subformat=icon-180$$xicon-180$$yOpenAccess
000138197 8564_ $$uhttps://pub.dzne.de/record/138197/files/fneur-06-00216.jpg?subformat=icon-640$$xicon-640$$yOpenAccess
000138197 8564_ $$uhttps://pub.dzne.de/record/138197/files/fneur-06-00216.pdf?subformat=pdfa$$xpdfa$$yOpenAccess
000138197 909CO $$ooai:pub.dzne.de:138197$$pdnbdelivery$$pdriver$$popenaire$$pVDB$$popen_access
000138197 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2810593$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b6$$kDZNE
000138197 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2810915$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b18$$kDZNE
000138197 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2812035$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b25$$kDZNE
000138197 9131_ $$0G:(DE-HGF)POF3-344$$1G:(DE-HGF)POF3-340$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lErkrankungen des Nervensystems$$vClinical and Health Care Research$$x0
000138197 9141_ $$y2015
000138197 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000138197 915__ $$0LIC:(DE-HGF)CCBYNV$$2V:(DE-HGF)$$aCreative Commons Attribution CC BY (No Version)$$bDOAJ
000138197 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bFRONT NEUROL : 2017
000138197 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal
000138197 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ
000138197 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000138197 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000138197 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000138197 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000138197 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Blind peer review
000138197 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000138197 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000138197 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central
000138197 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List
000138197 9201_ $$0I:(DE-2719)1011303$$kAG Heneka$$lNeuroinflammation, Biomarker$$x0
000138197 9201_ $$0I:(DE-2719)5000024$$kAG Maetzler$$lFunctional Neurogeriatrics$$x1
000138197 9201_ $$0I:(DE-2719)1440011$$kAG Schneider Göttingen$$lTranslational Dementia Research Göttingen$$x2
000138197 980__ $$ajournal
000138197 980__ $$aVDB
000138197 980__ $$aI:(DE-2719)1011303
000138197 980__ $$aI:(DE-2719)5000024
000138197 980__ $$aI:(DE-2719)1440011
000138197 980__ $$aUNRESTRICTED
000138197 9801_ $$aFullTexts
000138197 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1038/nrneurol.2010.4$$o10.1038/nrneurol.2010.4
000138197 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1016/S1474-4422(11)70014-X$$o10.1016/S1474-4422(11)70014-X
000138197 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1016/j.jalz.2011.05.2243$$o10.1016/j.jalz.2011.05.2243
000138197 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.2217/bmm.10.90$$o10.2217/bmm.10.90
000138197 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1258/acb.2009.008232$$o10.1258/acb.2009.008232
000138197 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1002/elps.200305992$$o10.1002/elps.200305992
000138197 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.4061/2010/986310$$o10.4061/2010/986310
000138197 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1373/clinchem.2005.058776$$o10.1373/clinchem.2005.058776
000138197 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1373/clinchem.2005.048629$$o10.1373/clinchem.2005.048629
000138197 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.4061/2010/635053$$o10.4061/2010/635053
000138197 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.2217/bmm.12.39$$o10.2217/bmm.12.39
000138197 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1371/journal.pone.0100784$$o10.1371/journal.pone.0100784
000138197 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.2217/bmm.12.46$$o10.2217/bmm.12.46
000138197 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1016/0022-3956(75)90026-6$$o10.1016/0022-3956(75)90026-6
000138197 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1136/jnnp.55.3.181$$o10.1136/jnnp.55.3.181
000138197 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1001/archneur.56.1.33$$o10.1001/archneur.56.1.33
000138197 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1212/WNL.34.7.939$$o10.1212/WNL.34.7.939
000138197 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1136/jnnp.51.3.353$$o10.1136/jnnp.51.3.353
000138197 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1212/WNL.43.10.2160$$o10.1212/WNL.43.10.2160
000138197 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1212/WNL.47.5.1113$$o10.1212/WNL.47.5.1113
000138197 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1016/j.clinbiochem.2013.12.024$$o10.1016/j.clinbiochem.2013.12.024
000138197 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1212/WNL.0b013e3181c47cc2$$o10.1212/WNL.0b013e3181c47cc2